These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10720212)

  • 21. The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial.
    Locatelli F; Hannedouche T; Jacobson S; La Greca G; Loureiro A; Martin-Malo A; Papadimitriou M; Vanholder R
    J Nephrol; 1999; 12(2):85-8. PubMed ID: 10378663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selective adsorption of homocysteine using HFR-on line technique].
    De Angelis A; Tullio T; Ferrannini M; Vega A; Dessì MR; Casciani S; Ruggia R; Pastore A; Cortese C; Splendiani G
    G Ital Nefrol; 2004; 21 Suppl 30():S106-10. PubMed ID: 15747291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients?
    Tessitore N; Poli A; Bedogna V; Corazza L; Campostrini N; Atti M; Sereni L; Castagna A; Girelli D; Pessolano G; Lupo A
    J Nephrol; 2018 Apr; 31(2):297-306. PubMed ID: 28353202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
    Klinger M; Arias M; Vargemezis V; Besarab A; Sulowicz W; Gerntholtz T; Ciechanowski K; Dougherty FC; Beyer U
    Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study.
    de Francisco AL; Sulowicz W; Klinger M; Niemczyk S; Vargemezis V; Metivier F; Dougherty FC; Oguey D;
    Int J Clin Pract; 2006 Dec; 60(12):1687-96. PubMed ID: 17109676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bicarbonate balance in hemodiafiltration (HDF): a comparison between two infusion methods of on-line prepared solution].
    Sidoti A; Borracelli D; Biagioli M; Ghezzi PM
    G Ital Nefrol; 2004; 21 Suppl 30():S177-80. PubMed ID: 15750980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On-line hemodiafiltration in Southeast Asia: a three-year prospective study of a single center.
    Tiranathanagul K; Praditpornsilpa K; Katavetin P; Srisawat N; Townamchai N; Susantitaphong P; Tungsanga K; Eiam-Ong S
    Ther Apher Dial; 2009 Feb; 13(1):56-62. PubMed ID: 19379171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
    Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
    Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
    Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy.
    Kim S; Oh KH; Chin HJ; Na KY; Kim YS; Chae DW; Ahn C; Han JS; Kim S; Joo KW
    Clin Nephrol; 2009 Dec; 72(6):442-8. PubMed ID: 19954721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective adsorption of homocysteine using an HFR-ON LINE technique.
    Splendiani G; De Angelis S; Tullio T; Ferranini M; Dessì MR; Pastore A; Casciani S; Liberatoscioli L; Federici G; Cortese C
    Artif Organs; 2004 Jun; 28(6):592-5. PubMed ID: 15153154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.
    Chan K; Moran J; Hlatky M; Lafayette R
    Nephrol Dial Transplant; 2009 Jun; 24(6):1956-62. PubMed ID: 19176685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
    Lacson E; Ofsthun N; Lazarus JM
    Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.